165 related articles for article (PubMed ID: 15868331)
1. [Prescription of glucocorticoids by rheumatologists in patients with rheumatoid arthritis in Germany].
Thiele K; Buttgereit F; Huscher D; Zink A;
Z Rheumatol; 2005 Apr; 64(3):149-54. PubMed ID: 15868331
[TBL] [Abstract][Full Text] [Related]
2. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
Zink A; Listing J; Ziemer S; Zeidler H;
J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
[TBL] [Abstract][Full Text] [Related]
3. A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis.
Meyfroidt S; Hulscher M; De Cock D; Van der Elst K; Joly J; Westhovens R; Verschueren P
Clin Rheumatol; 2015 May; 34(5):861-9. PubMed ID: 25711874
[TBL] [Abstract][Full Text] [Related]
4. Half of U.K. patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study.
Black RJ; Joseph RM; Brown B; Movahedi M; Lunt M; Dixon WG
Arthritis Res Ther; 2015 Dec; 17():375. PubMed ID: 26702817
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of osteoporosis and rheumatoid arthritis in accordance with German guidelines. Results of a survey of patients, primary care physicians and rheumatologists].
Heberlein I; Demary W; Bloching H; Braun J; Buttgereit F; Dreher R; Kuhn C; Lange U; Zink A; Zeidler H; Häntzschel H; Raspe H
Z Rheumatol; 2011 Sep; 70(7):592-601. PubMed ID: 21755301
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing rheumatologists' prescription of biological treatment in rheumatoid arthritis: an interview study.
Kalkan A; Roback K; Hallert E; Carlsson P
Implement Sci; 2014 Oct; 9():153. PubMed ID: 25304517
[TBL] [Abstract][Full Text] [Related]
7. Patterns of glucocorticoid prescribing and provider-level variation in a commercially insured incident rheumatoid arthritis population: A retrospective cohort study.
Wallace BI; Lin P; Kamdar N; Noureldin M; Hayward R; Fox DA; Curtis JR; Saag KG; Waljee AK
Semin Arthritis Rheum; 2020 Apr; 50(2):228-236. PubMed ID: 31522762
[TBL] [Abstract][Full Text] [Related]
8. Combination of disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis. A survey of Alabama rheumatologists.
Baum SK; Tracy IC; Henderson EH; Alarcón GS
Arthritis Care Res; 1991 Mar; 4(1):48-51. PubMed ID: 11188587
[TBL] [Abstract][Full Text] [Related]
9. Current use of glucocorticoids in patients with rheumatoid arthritis in Germany.
Thiele K; Buttgereit F; Huscher D; Zink A;
Arthritis Rheum; 2005 Oct; 53(5):740-7. PubMed ID: 16208641
[TBL] [Abstract][Full Text] [Related]
10. Prescription rheumatology practices among Mexican specialists.
Goycochea-Robles MV; Arce-Salinas CA; Guzmán-Vázquez S; Cardiel-Ríos MH
Arch Med Res; 2007 Apr; 38(3):354-9. PubMed ID: 17350489
[TBL] [Abstract][Full Text] [Related]
11. Variability in Glucocorticoid Prescribing for Rheumatoid Arthritis and the Influence of Provider Preference on Long-Term Use of Glucocorticoids.
George MD; Baker JF; Wallace B; Chen L; Wu Q; Xie F; Yun H; Curtis JR
Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1597-1605. PubMed ID: 32702188
[TBL] [Abstract][Full Text] [Related]
12. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
[TBL] [Abstract][Full Text] [Related]
13. Assessment of coxib utilization by rheumatologists for nonsteroidal antiinflammatory drug gastroprotection prior to the coxib market withdrawals.
Greenberg JD; Bingham CO; Abramson SB; Reed G; Kishimoto M; Hinkle K; Kremer J
Arthritis Rheum; 2006 Aug; 55(4):543-50. PubMed ID: 16874798
[TBL] [Abstract][Full Text] [Related]
14. [Healthcare research in rheumatology. Current state].
Zink A
Z Rheumatol; 2014 Mar; 73(2):115-22. PubMed ID: 24549920
[TBL] [Abstract][Full Text] [Related]
15. Variations among rheumatologists in prescribing and monitoring of disease modifying antirheumatoid drugs.
Kay EA; Pullar T
Br J Rheumatol; 1992 Jul; 31(7):477-83. PubMed ID: 1352723
[TBL] [Abstract][Full Text] [Related]
16. Are rheumatologists' treatment decisions influenced by patients' age?
Fraenkel L; Rabidou N; Dhar R
Rheumatology (Oxford); 2006 Dec; 45(12):1555-7. PubMed ID: 16690762
[TBL] [Abstract][Full Text] [Related]
17. Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
López-Longo FJ; Seoane-Mato D; Martín-Martínez MA; Sánchez-Alonso F;
Rheumatol Int; 2018 Apr; 38(4):589-598. PubMed ID: 29368023
[TBL] [Abstract][Full Text] [Related]
18. Utilization of health services and prescription patterns among lupus patients followed by primary care physicians and rheumatologists in Puerto Rico.
Molina MJ; Mayor AM; Franco AE; Morell CA; López MA; Vilá LM
Ethn Dis; 2008; 18(2 Suppl 2):S2-205-10. PubMed ID: 18646350
[TBL] [Abstract][Full Text] [Related]
19. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
Osiri M; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
[TBL] [Abstract][Full Text] [Related]
20. [Outpatient rheumatologic treatment in Germany].
Edelmann E
Z Rheumatol; 2014 Mar; 73(2):123-34. PubMed ID: 24659148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
